Skip to main content

Peer Review reports

From: Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma

Original Submission
13 Apr 2021 Submitted Original manuscript
26 May 2021 Reviewed Reviewer Report
31 May 2021 Reviewed Reviewer Report
15 Jun 2021 Author responded Author comments - Hideki Iijima
Resubmission - Version 2
15 Jun 2021 Submitted Manuscript version 2
7 Jul 2021 Reviewed Reviewer Report
3 Aug 2021 Author responded Author comments - Hideki Iijima
Resubmission - Version 3
3 Aug 2021 Submitted Manuscript version 3
Publishing
22 Aug 2021 Editorially accepted
31 Aug 2021 Article published 10.1186/s12885-021-08724-5

You can find further information about peer review here.

Back to article page